2631005-84-8

Cap-dependent endonuclease-IN-9 Chemical Structure
2631005-84-8

Chemical Structure

Cap-dependent endonuclease-IN-9

  • CAS No.: 2631005-84-8
  • Formula:C29H22F2N4O7S
  • Molecular Weight:608.57

IUPAC Name: (1R,2S)-1-((2S,4R)-4-butyl-1-methylpyrrolidine-2-carboxamido)-1-((2R,3R,4S,5R,6R)-5-((hexadecanoyl-d31)oxy)-3,4-dihydroxy-6-(methylthio)tetrahydro-2H-pyran-2-yl)propan-2-yl hexadecanoate-d31

InChIKey: RXUYYAAWOMIREX-NOZRDPDXSA-N

SMILES: O=C1N2[C@@H](CC3=C(N=CO3)C2)N([C@H]4C5=CC=C(F)C(F)=C5CSC6=CC=CC=C64)N7C1=C(C(C=C7)=O)OCOC(OC)=O

Biological Activity: Cap-dependent endonuclease-IN-9 is a potent inhibitor of cap-dependent endonuclease (CEN). Not only can Cap-dependent endonuclease-IN-9 inhibit influenza virus well, but also has lower cytotoxicity, better in vivo agent kinetic properties and in vivo pharmacodynamic properties. Cap-dependent endonuclease-IN-9 has strong inhibitory effect on RNA polymerase activity of A virus (extracted from patent CN112521386A, compound VI-1)[1].

Cat. No. Product Name Purity Description Pricing
HY-143755
Cap-dependent endonuclease-IN-9 Cap-dependent endonuclease-IN-9 is a potent inhibitor of cap-dependent endonuclease (CEN). Not only can Cap-dependent endonuclease-IN-9 inhibit influenza virus well, but also has lower cytotoxicity, better in vivo agent kinetic properties and in vivo pharmacodynamic properties. Cap-dependent endonuclease-IN-9 has strong inhibitory effect on RNA polymerase activity of A virus (extracted from patent CN112521386A, compound VI-1).
Pricing 
Expand Hide
loading...
/
  • /
loading...
Size Price
Stock Quantity Availability Operate
/
In-stock
(Estimated to ship on )
(Estimated to ship TODAY)
Estimated to ship on
(Estimated to ship TODAY)

Amount:

USD 0.00

This product is a controlled substance and not for sale in your territory.

This product is not for sale in your territory.

This compound is listed in the SVHC (Substances of Very High Concern) candidate list of ECHA (European Chemicals Agency).

Pricing 
Expand Hide

References